Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Current pharmacotherapies for major depressive disorder (MDD) have a distinct lag of onset that can prolong distress and impairment for patients, and real-world effectiveness trials further suggest that antidepressant efficacy is limited in many patients. All currently approved antidepressant medica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Neuropharmacol
Autors principals: Jaso, Brittany A., Niciu, Mark J., Iadarola, Nicolas D., Lally, Níall, Richards, Erica M., Park, Minkyung, Ballard, Elizabeth D., Nugent, Allison C., Machado-Vieira, Rodrigo, Zarate, Carlos A.
Format: Artigo
Idioma:Inglês
Publicat: Bentham Science Publishers 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5327449/
https://ncbi.nlm.nih.gov/pubmed/26997505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666160321123221
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars